J. Curtis Nickel, MD, FRCSC - Urology
Dr. J. Curtis Nickel reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Nickel is a Professor of Urology at Queen's University in Kingston, Ontario, Canada. His research has been in the fields of inflammatory diseases of the urinary tract and benign diseases of the prostate gland. He has written more than 340 scientific papers, reviews, chapters, and books on these subjects. Dr. Nickel maintains a laboratory at Queen's University, funded by peer-reviewed and industry grants. Dr. Nickel participates-as organizer, chairman, invited lecturer, or visiting professor-in many local, national and international university events. He has given invited lectures in more than 35 countries and is on the scientific or review panel of numerous granting agencies. He is a regular reviewer for many urological and medical journals and is on the editorial board of a number of national and international urological journals.
Education and Training
MD: Queen's University, Kingston, ON, 1978
Internship in Surgery: Memorial University of Newfoundland, 1978-1979
Residency in Urology: Queen's University, Kingston, ON, 1979-1980
Residency in Surgery: Memorial University of Newfoundland, 1980-1981
Residency in Urology: Memorial University of Newfoundland, 1981-1982
Chief Resident in Urology: Queen's University, Kingston, ON, 1982-1983
Academic Appointments
Queen's University, Department of Urology, Kingston, ON:
- Professor of Urology, 1994-present
- Associate Professor, 1988-1994
- Assistant Professor, 1984-1989
- Lecturer, 1983
Research Fellow, University of Calgary, Alberta Heritage Foundation for Medical Research, Division of Microbiology, Department of Biology, Calgary, AL, 1983-1984
Financial Disclosure
The final approval of Healthwise content is always made by a clinician with no financial conflicts.
Dr. Nickel serves as a consultant for the following:
- Merck Frosst Canada
- GlaxoSmithKline
- Sanofi-Aventis
- Boehringer-Ingelheim
- Ford Laboratories
- Threshold Pharmaceuticals, Inc.
- Plethora Solutions
Current as of: January 10, 2014
Author: Healthwise Staff
